News

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...
To assess malignancy risk, researchers reviewed all CT scans performed as part of a lung cancer screening programme between ...
SUPER sensitive cancer blood tests will be rolled out to NHS patients in a world first. People diagnosed with breast or lung ...
Lung cancer is the leading cause of cancer-related deaths in Australia. In 2024, it was the fifth most diagnosed cancer ...
A life-saving initiative is coming to Preston - aimed detecting the early stages of lung cancer. People aged between 55 to 74 ...